Physician profile
Peter H Kehoe
NPI 1164415139
$166,924.57
in general payments reported to CMS, 2019-2025
16 companies · $241 in 2025
The $241 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $51K · 2021: $34K · 2022: $57K · 2023: $13K · 2024: $594 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $1,424 · Entertainment: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,000.00 |
| Food and Beverage | $1,423.91 |
| Entertainment | $123.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $94,863.50 | 2019-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Heru, INC. | $66,530.31 | 2022-2023 | Heru Hmd |
| Coopervision INC. | $1,318.55 | 2019-2024 | Myday Contact Lens, Clariti Contact Lens |
| Allergan, INC. | $1,232.50 | 2021-2022 | |
| Alcon Vision LLC | $1,138.24 | 2021-2025 | Total30, Precision 1, Precision7 |
| Bausch & Lomb Americas INC. | $442.47 | 2022-2025 | Infuse, Biotrue |
| Maculogix, INC. | $392.68 | 2019-2020 | |
| Lombart Brothers, INC. | $249.55 | 2019-2023 | Opd-III |
| Abbvie INC. | $170.09 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $151.14 | 2019 | |
| Lkc Technologies, INC. | $126.81 | 2024 | |
| Optovue, INC. | $125.92 | 2019 | |
| Sight Sciences, INC. | $84.95 | 2024 | Tearcare System |
| Sun Pharmaceutical Industries INC. | $59.05 | 2019-2021 | |
| Shire North American Group INC | $26.06 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $12.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Kehoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.